Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S26 pseudogene 5 (RPS26P5) is a processed pseudogene related to the functional RPS26 gene, which encodes a component of the 40S ribosomal subunit[1][3][5]. Like other processed pseudogenes of ribosomal protein genes, RPS26P5 is considered non-functional; it does not produce a functional protein and is not involved in biological processes, disease association, or as a therapeutic target[1][3][5]. The functional RPS26 gene is implicated in ribosome biogenesis and diseases such as Diamond-Blackfan anemia; however, pseudogenes such as RPS26P5 have no therapeutic, biomarker, or disease relevance, and there are no known drugs or safety issues directly connected to this entry[1][3][4][5]. **Note:** - RPS26P5 is not a protein-coding gene, nor is it a therapeutic target. - Most information about disease, molecular function, and drug targeting refers to the functional RPS26 gene, not its pseudogenes. - RPS26P5 lacks biological, clinical, or pharmacological relevance[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S26 pseudogene 5 (RPS26P5).